2 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
lowered CV events in T2DM ... lowered CV events in T2DM ... + T2DM; first renal ... with or without T2DM ... SGLT2 #inhibitors #EBM
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
and metformin in T2D ... and CKD. ... sulfonylurea; T2D ... , #KDIGO2020 #CKD ... management #treatment #CHART